Related Experiment Video
Updated: Jul 20, 2026

16:49
Multifocal Electroretinograms
Published on: December 4, 2011
A multifocal electroretinogram model predicting the development of diabetic retinopathy
Marcus A Bearse1, Anthony J Adams, Ying Han
1School of Optometry and Vision Science Program, University of California, Berkeley, Berkeley, CA 94720-2020, USA.
Progress in Retinal and Eye Research
|September 5, 2006
Summary
Diabetic retinopathy prediction is improved using multifocal electroretinogram (mfERG) to identify at-risk retinal locations. This functional measure aids early detection and treatment of diabetic eye disease, saving sight.
Area of Science:
- Ophthalmology
- Diabetology
- Medical Imaging
Background:
- Diabetes is a growing epidemic with diabetic retinopathy as a leading cause of blindness.
- Early detection and treatment of diabetic retinopathy are crucial for preserving vision.
- Identifying functional indicators of retinal health is essential for evaluating new therapies.
Purpose of the Study:
- To establish functional indicators and predictors of diabetic retinopathy.
- To utilize the multifocal electroretinogram (mfERG) for objective retinal function assessment.
- To develop models for predicting the location and onset of diabetic retinopathy.
Main Methods:
- Utilized multifocal electroretinogram (mfERG) to measure local retinal function.
- Correlated mfERG functional data with structural (vascular) abnormalities.
- Developed and validated multivariate models incorporating mfERG implicit time and risk factors for prediction.
Main Results:
- mfERG implicit time effectively revealed functional alterations in diabetic retinas.
- A multivariate model achieved 86% sensitivity and 84% specificity in predicting new retinopathy development within one year.
- Models demonstrated predictive power for retinopathy development over one- and two-year follow-ups, in eyes with and without baseline retinopathy.
Conclusions:
- mfERG provides a powerful tool for screening, monitoring, and potentially treating diabetic retinopathy.
- Predictive models can identify at-risk retinal locations, aiding clinical management and clinical trial design.
- This approach can optimize clinical trials by reducing sample size and duration.

